Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints"
George Cholankeril1, Jennifer R Kramer2, Xian Yu2
1Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Hepatology Program, Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, Texas, USA.
Journal of Hepatology
|July 22, 2024
Abstract
No abstract available in PubMed .
More Related Videos
09:50Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
Published on: August 20, 2021
3.4K
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
2.4K
